The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy.
Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM). The epidemiology, clinical and prognostic significance of AF in DCM are poorly defined. Analyse AF impact and prognostic role in DCM, explore the concept of AF-induced DCM. Hospital records of 285 DCM patients from 2012-2018 were analysed. AF was present in 89 (31%) patients who were older, more frequently male, had higher BMI, NYHA class, heart rate (HR), creatinine, larger atria (all p < 0.05) than non-AF patients. During a follow-up [35 (24) months] 20 (24%) out of 82 patients with AF and 22 (12%) out of 188 patients without AF died (p = 0.007). AF was independently associated with worse outcome (HR 2.4 [95%CI 1.3-4.3]). AF was found to be the major cause of DCM in 21 patients (24%). These patients experienced: shorter duration of symptoms and QRS, were of a lower NYHA class, smaller left ventricle, higher HR, haemoglobin and LDL, required lower furosemide doses. The diagnostic accuracy of the most optimal predictive model for AF-DCM, consisting of DCM duration, NYHA class, HR and haemoglobin was 0.935 [95%CI 0.903-0.967]. Despite numerical differences, survival in AF-DCM was similar to DCM with AF (p = 0.15). Almost one-third of DCM patients suffered from AF. Most of the parameters analysed differentiate patients with and without AF. AF was found to be an independent prognostic factor in DCM. One-fourth of DCM patients with AF met the criteria for the diagnosis of AF-DCM.